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Symptoms associated with chlamydial
infection among minority women
T. S. Wen MD, J. M. Piper MD,
J. E. Korte PhD, R. N. Shain PhD,
E. R. Newton MD, S. Perdue DrPH,
J. D. Champion PhD and A. E. C. Holden MA
Department of Obstetrics and Gynecology,
The University of Texas Health Science Center at
San Antonio, San Antonio, Texas
Objectives: To assess the patterns of reported
symptoms and signs in women infected with
Chlamydia trachomatis alone (CT) vs. Chlamydia
with bacterial vaginosis (BV), Candida (CA),
gonorrhea (GC) or Trichomonas (TR) infection vs.
other infections (BV, CA, GC, TR) without
Chlamydia.
Study design: 602 African- and Mexican-
American women with positive tests for GC
(Gen-Probe), CT (Gen-Probe) or TR (culture)
were enrolled in a randomized trial of a behav-
ioral-cognitive intervention to reduce STD re-
currence. Each woman underwent extensive
questioning regarding genito-urinary symptoma-
tology and had a standardized physical exam,
including testing for common genital pathogens.
Genito-urinary symptoms (patient report) and
signs (clinician exam) were compared between
women with CT only, CT+ (CT plus BV, CA,
GCorTR)andCT-(BV, CA,GCorTRwithout
CT). Categories of disease were initially analyzed
separately and were collapsed based on the homo-
geneity of results. We present here only baseline
data,atwhichtimeallthewomenwereinfected.
Results: Genito-urinary symptoms were com-
monly reported by women with CT only
(n = 120), CT+ (n = 301) and CT- (n = 181)
(Table 1). Painsymptomswere common:abdomi-
nal pain (38–42%), pain with sex (11–19%) and
pain with urination (17–22%).
Genito-urinary symptoms were severe enough to
cause the woman to take an action (stop having
sex, douche,use medicine, orgo to doctor)in 44%
ofCTonly,47%ofCT+and47%ofCT-cases.
Conclusions: A significant portion of women
with genital infections report genito-urinary
symptoms when specifically questioned. In con-
trast to other cross-sectional studies describing
chlamydia as an asymptomatic infection, in our
population women with chlamydial infection
alone reported genito-urinary symptoms com-
parable to those in women with other vaginal
infections.
Lower genital tract infection and
endometritis: insight on subclinical pelvic
inflammatory disease
Harold C. Wiesenfeld MD, CM,
Sharon L. Hillier PhD, Marijane A. Krohn PhD,
Antonio A. Amortegui MD, R. Phillip Heine MD,
Daniel V. Landers MD and Richard L. Sweet MD
University of Pittsburgh, Magee-Women’s Hospital
Objectives: To investigate the association
between lower genital tract infections (LGTI) and
histologic endometritis among women without
evidence of acute pelvic inflammatory disease
(PID).
Study design: An observational study in which
556women atrisk forlowergenitaltractinfections
and without clinical evidence of acute PID were
enrolled from STD and ambulatory clinics.
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Discharge
Hx
Mod/Heavy
Hx
Yellow/Grn
Exam-
Vag.
Exam-
Cx
Hx Vaginal
Itch
Hx Vaginal
Odor
CT only
CT+
CT
59.7%
64%
64.7%
55.1%
54.6%
47.8%
83%
87.9%
86.2%
45.8%
41.2%
38.1%
34.2%
36.4%
40.6%
31.6%
42.2%
42.6%
Table 1 Genito-urinary symptoms reportedVaginal samples were collected for Gram stain for
bacterial vaginosis (BV) score, and cervical samples
were obtained for culture for Neisseria gonorrhoeae
and polymerase chain reaction (PCR) for
Chlamydia trachomatis. Endometrial biopsies were
processed for histologic analysis. Acute histologic
endometritis was diagnosed in the presence of
> 5 neutrophils/400X and > 1 plasma cell/120X
of endometrial tissue, and plasma cell endometritis
was defined as the presence of > 1 plasma
cell/120X field.
Results: Acute histologic endometritis was
present in 74 women (13.3%), while 126 women
(22.7%) had plasma cell endometritis and 356
women (64.0%) did not have endometritis.
Acute histologic endometritis and plasma cell
endometritis were more common among African-
American women, women in the proliferative
phase of the menstrual cycle, and among women
who douched. Logistic regression analysis showed
that BV, gonorrhea and chlamydia elevated the
risk of acute but not plasma cell endometritis
(Table 1).
Conclusions: Endometritis was common among
women in the study with LGTI who did not have
acute PID. Gonorrhea, chlamydia, and bacterial
vaginosis were independently associated with
acute histologic endometritis, but not plasma cell
endometritis. These findings may represent sub-
clinical PID. The reproductive sequelae of sub-
clinical PID, such as infertility, ectopic pregnancy
andchronicpelvicpain,remaintobecharacterized.
Vaginal polymorphonuclear leukocytes and
bacterial vaginosis as markers for acute
endometritis
M. H. Yudin MD, S. L. Hillier PhD,
H. Wiesenfeld MD, CM, M. A. Krohn PhD,
A. Amortegui MD and R. L. Sweet MD
University of Pittsburgh/Magee-Women’s Hospital,
Pittsburgh, PA
Objective: To determine whether vaginal poly-
morphonuclear leukocytes (PMNs) predict acute
endometritis among women withoutsymptoms of
pelvic inflammatory disease (PID).
Study design: Five hundred and forty-four
women were enrolled fromMay1998to February
2001. They were recruited from four clinical sites.
Inclusion criteria included age 15–30, infection
with orrisk factorsfor Neisseria gonorrhoeae(GC) or
Chlamydia trachomatis (CT), or clinically diagnosed
symptomatic bacterial vaginosis (BV). Vaginal
Gram stains were evaluated for the presence of
both BV and PMNs, and an endometrial biopsy
was performed. Acute endometritis was diagnosed
based on the presence of plasma cells and PMNs
in the biopsy specimen. Statistical analysis was
performed to determine whether there was an
association between thepresence of vaginal PMNs
and acute endometritis, after stratifying for BV and
sexually transmitted diseases (STDs).
Results: Of the 544 subjects enrolled 357 (65.6%)
had BV, 11% had GC, and 21% had CT. Of those
with BV, 158 (44.3%) had vaginal PMNs present,
while 85 (45.4%) of those without BV had vaginal
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Acute histologic endometritis Plasma cell endometritis
OR 95% CI OR 95% CI
Vaginal smear
Bacterial vaginosis (BV)
Intermediate flora
BV or intermediate flora
Normal flora
Gonorrhea (cervix)
Chlamydia (cervix)
2.9
2.0
2.7
Ref
2.7
3.1
1.1–7.6
0.6–6.1
1.0–7.0
1.3–5.8
1.7–5.7
1.5
1.3
1.5
Ref
1.8
1.7
0.8–2.8
0.6–2.8
0.8–2.7
0.9–3.6
0.9–2.9
OR, odds ratio; CI, confidence interval
Table 1 Association between endometrisis and vaginal bacteriaPMNs present. Women with vaginal PMNs had
a significantly higher prevalence of acute
endometritis than those without vaginal PMNs
(20% vs. 7%, p < 0.001). However, as shown
below, women with both BV and vaginal PMNs
had the highest risk of acute endometritis
(Table 1).
Since PMNs couldbe related to concurrentSTDs,
women with GC or CT were excluded and
the analysis was performed again; BV and PMNs
remained associated with acute endometritis (OR
6.0; 95% CI, 1.2–40).
Conclusions: Vaginal PMNs are associated with
acute endometritis, independent of BV or con-
current STDs.
Influences of vaginal and embryo transfer
catheter microbiology on early pregnancy
loss following in vitro fertilization
L. O. Eckert MD, D. E. Moore MD,
K. Agnew BS and D. A. Eschenbach MD
Objectives: In women undergoing in vitro
fertilization (IVF)bacterial vaginosis (BV) hasbeen
associated with increased early pregnancy loss, but
no change in conception rate1. We conducted a
pilot study of 91women undergoingIVF to deter-
mine the influences of BV and IVF catheter tip
cultures on conception and early pregnancy loss.
Study design: From May 1997 to May 1998, 91
women undergoing IVF at the University of
Washingtonwereenrolledinapilotstudytodeter-
mine the effect of vaginal and catheter tip bacteria
on live birth rate (LBR), and early pregnancy loss.
All women had vaginal cultures and Gram stains
(scored with the Nugent criteria), and embryo
transfer cathetertips cultured.Early pregnancyloss
was defined as a positive serum human chorionic
gonadotropin (hCG) on day 14 after transfer, but
no fetal heartbeat on ultrasound 6 weeks after
transfer.
Results: LBR was 29 of 91 (31.9%), and early
pregnancy loss was 14 of 42 (33.3%). The table
below presents the conceptionrate and early preg-
nancy loss in women examined for BV and cathe-
ter tip cultures.
Conclusions: This small pilot study suggests that
IVF patients with BV and catheter tip isolation of
viridans streptococci may have decreased concep-
tionratesandincreased earlypregnancyloss.Those
women with H2O2 + Lactobacillus on the catheter
tip had the highest conception rate, and no early
pregnancyloss.While this studyis small, it suggests
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Number
of
subjects
Acute
endometritis
Odds
ratio
(OR)
95%
Confidence
interval
BV+, PMN+
BV-, PMN+
BV+, PMN-
BV-, PMN-
158
85
199
102
28 (17.7%)
11 (12.9%)
14 (7.0%)
3 (2.9%)
7.1
4.9
2.5
Reference
(2.0–30)
(1.2–23)
(0.7–11)
Reference
Table 1 Correlation of the incidence of acute endo-
metritis with polymorphonuclear leukocytes and bacte-
rial vaginosis
Factor + hCG at day 14 Early pregnancy loss
Vaginal Gram stain
BV flora (n = 8)
Int. flora (n = 33)
Normal flora (n = 50)
Catheter tip culture
Viridans streptococci (n = 17)
H2O2 + Lactobacillus (n = 10)
No bacteria (n = 57)
2 (25.0%)
13 (39.4%)
27 (54.0%)
3 (17.6%)
7 (70.0%)
18 (31.6%)
1 of 20 (50.0%)
5 of 13 (38.5%)
8 of 27 (29.6%)
2 of 3 (66.7%)
0.0
6 of 18 (33.3%)
Table 1 Influences of vaginal and embryo transfer catheter microbiology on early pregnancy lossthat a larger prospective trial is warranted. Treat-
ment of BV, viridans streptococci or other patho-
gens, and enhancement of H2O2 + Lactobacillus
may lead to a higher IVF success rate.
Reference
1. Ralph S, Rutherford A, Wilson J. Influence of
bacterial vaginosis on conception and miscarriage in
the first trimester: cohort study. Br Med J 1999;
319(7204):220–3
The risk of acquisition of herpes simplex
virus (HSV) during pregnancy: a prospec-
tive couples study
Carolyn Gardella MD, Rhoda Ashley PhD,
Sylvia Berry MS, Stacy Selke MS, Judy Zeh PhD,
Lawrence Corey MD, Zane Brown MD
DepartmentsofObstetricsandGynecology,Biostatistics,
and Laboratory Medicine,
University of Washington, Seattle, WA
Objective: To determine the prevalence of
herpes simplex virus (HSV) serologic discord
between partners and the risk factors for trans-
mission of HSV during pregnancy among HSV
discordant couples.
Studydesign: Serumsampleswereobtainedfrom
women at the first prenatal visit, at the time of
labor, and from their partners at any time during
pregnancy or puerperium to test for HSV by
Western blot. A woman was HSV-1 susceptible if
she was HSV-1 seronegative and her partner was
HSV-1 seropositive. Similarly, she was HSV-2
susceptible if she was HSV-2 seronegative and her
partner was HSV-2 seropositive. The frequencyof
maternal seroconversion was calculated as theratio
of the number of women who had HSV-1 or -2
seroconversionduringpregnancytothenumberof
women HSV-1 or HSV-2 susceptible.
Results: Of 4064 couples enrolled, maternal pre-
natal, delivery and partnersera were available from
3071 (75.6%) couples. Thirty-two percent of
enrolled women were HSV seronegative, 46%
were HSV-1, 10% were HSV-2, and 12% were
HSV-1 and -2 seropositive. Thirty-five percent
of the men were HSV seronegative, 49% were
HSV-1,8%wereHSV-2,and8%wereHSV-1and
-2 seropositive. Of 3071 couples, 1457 (47.4%)
were serologically discordant with 664 (21.6%)
women being the susceptible partner. Among
susceptible women,540 (81.3%) were HSV-1 sus-
ceptible and 124 (18.7%) were HSV-2 susceptible.
Of the HSV-1 susceptible women, 393 were HSV
negative, of whom 13 (3.3%) seroconverted to
HSV-1, and 147 were HSV-2 seropositive, of
whom 1 (0.7%) seroconverted to HSV-1. Of the
HSV-2 susceptible women, 32 were HSV nega-
tive, of whom 7 (21.9%) seroconverted to HSV-2,
and 92 were HSV-1 seropositive, of whom 10
(10.9%) seroconverted to HSV-2.
Conclusions: The risk for seroconversion to
HSV-2 was greatest (21.9%) among susceptible
women whowere HSV seronegative. Partnertest-
ing can identify women at high risk for primary
HSV-2 infection during pregnancy for targeted
safe-sex interventions.
Acknowledgement: This research was sup-
ported by NIAID grant AI-30731.
A double-blind, randomized, placebo-
controlled trial of acyclovir in late
pregnancy for reduction of herpes simplex
virus (HSV) shedding and cesarean section
D. H. Watts, Z. A. Brown, D. Money, S. Selke,
J. Aura, V. Remple, A. Cent, A. Hobson, S. Sacks,
S. Berry and L. Corey
University of Washington and University of British
Columbia
Objective: To assess the efficacy of acyclovir
compared toplaceboinreducingtherateofgenital
herpes simplex virus (HSV) culture and poly-
merasae chain reaction (PCR) positivity and
cesarean section among pregnant women with
symptomatic genital HSV.
Study design: HIV-negative pregnant women
withatleast onesymptomaticrecurrenceofgenital
HSV inthepastyear wererandomized toacyclovir
400mg TIDor identicalplacebo from 36 weeksof
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visits, completed a daily symptom diary and
obtained daily perineal and cervico-vaginal speci-
mensathomeforHSVcultureandDNAdetection
by PCR. Obstetrical management was at the
discretion of the attending physician; cesarean
delivery for HSV was carried out if lesions were
present. Analyses were done using chi-square and
two-tailed Fisher’s exact tests.
Results: There were no significant differences
between treatment groups in demographic or
obstetricalcharacteristics, orinthepatients’ history
ofherpes.Outcomesaresummarizedinthetable.
Neonatal outcomes were similar between
groups. No cases of neonatal HSV occurred.
Conclusions: Acyclovir, 400 mg TID orally, sig-
nificantly reduced but did not eliminate HSV
lesions and detection by culture and PCR in late
pregnancy among women with symptomatic
recurrent HSV. While C-section rates for HSV
were reduced by suppressive therapy, we were not
able to show a statistically significant reduction.
Measurement of biogenic amines by ion
mobility spectrometry (IMS) as an indica-
tion for bacterial vaginosis (BV)
Chaim Walter, Silberstein Tali, Karpas Zeev,
Lorber Avi, Katz Miriam and Mazor Moshe
Department of Obstetrics and Gynecology, Soroka
University Medical Center Faculty of Health Sciences,
Ben Gurion University of the Negev, Beer Sheva, and
the Nuclear Research Center, Israel
Objective: The presence of elevated levels of
biogenic amines, such as putrescine, cadaverine
and trimethylamine (TMA), in vaginal fluid is
indicative of bacterial vaginosis (BV) and other
pathological conditions. These are usually
expressed intheAmseltestasapositiveresultinthe
‘Whiff test’and an increase in thepHofthesample
topH>4.5. Ionmobilityspectrometry(IMS)isan
instrumental techniqueforidentifying compounds
and determining their concentrations, based on
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Outcome
Acyclovir
(n = 87)
Placebo
(n = 83) p
Any + genital
culture
Any + genital
PCR
Daysculture+
Days PCR+
Lesions at
delivery
PCR+ at
delivery
C-section for
HSV
10 (11.5%)
30/84 (35.7%)
17/1833 (0.9%)
96/1622 (5.9%)
4 (4.6%)
1/28 (3.6%)
3/87 (3.5%)
33 (39.8%)
45/75 (60.0%)
72/1722 (4.2%)
244/1317 (18.5%)
12 (14.5%)
6/24 (25.0%)
9/83 (10.8%)
< 0.01
0.01
< 0.01
< 0.01
0.04
0.04
0.08
Table 1 Efficacy of acyclovir for the treatment of
genital herpes simplex virus (HSV)
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Figure 1 Ion mobility spectrogram of vaginal fluid in bacterial vaginosis (BV). TMA, trimethylamine; Put, putrescine;
Cad, cadaverinemeasurement of the velocity of ions (ion mobility)
drifting through a bath gas (usually air at ambient
pressure) under the influence of an electric
field. The technique is particularly sensitive to
amines.
Study design: A novel method for determin-
ing the biogenic amines content in a vaginal
swab sample by use of IMS was developed.
A few drops of an alkaline solution are added
to the sample to enhance the emanation of
the amines, and the mobility spectrum of
the vapors entering the instrument is recorded.
The analysis of a sample takes less than a
minute.
Results: Elevated levels of TMA were found in
vaginal fluid swabs taken from subjects diagnosed
as having BV. Swabs taken during return visits,
after treatment, clearly showed that the disappear-
ance of the symptoms in the Amsel test were con-
cordant with the return to normal TMA levels
(Figure 1).
Conclusion: Preliminary work shows that ion
mobility spectrometry has potential for diagnosis
of other types of vaginitis.
Congenital cytomegalovirus infection
presenting as a molar pregnancy
Christine Isaacs MD and Mara J. Dinsmoor MD
Department of Obstetrics and Gynecology, MCVH
& P of the VCU Health System, Richmond, VA
Objective: To report an unusual case of congeni-
tal cytomegalovirus (CMV) infection that pre-
sented with findings suggestive of a (partial) molar
pregnancy.
Description of case: A 22-year-old G2P0A1,
at 19 weeks and 6 days was referred with ‘swollen
feet and a headache’. Her medical history included
a ‘thyroid problem’ for which she had been taking
‘some medicine’ until one month previously.
Physical exam revealed blood pressure 135/74,
P-80. She had no periorbital edema or thyro-
megaly. Her abdomen was tense and nontender
and the fundal height was 23 cm with positive
FHTs. 1+ lower extremity edema and 2+ deep
tendon reflexes were present. Laboratory evalua-
tion revealed 2+ urinary protein, b-hCG 502
306 mIU/ml, ast 199 units/l, ALT 175 units/l and
thyroid stimulating hormone (TSH) 0.1 mIU/ml.
Uric acid, ammonia, renal function, coagulation
studies and platelets were normal. Ultrasound
revealed a 19-week pregnancy with oligo-
hydramnios and placentomegaly (14 cm in thick-
ness entrapping the fetus), ascites and echogenic
bowel. The heart appeared to be enlarged but
structurally normal. The patient elected to under-
go termination. We suspected that this constella-
tion of findings represented a partial mole with
associated pre-eclampsia and thyrotoxicosis. Find-
ings at D & E included a large amount of placental
tissue with hydropic villi. Postoperatively, the
LFTs quickly returned to normal levels. Serologic
evaluation ultimately revealed positive CMV IgM
and IgG. Pathologic examination of the placenta
revealed no histologic evidence of a molar
pregnancy. Eosinophilic cytoplasmic and nuclear
inclusions, consistent with CMV infection, were
noted. Further immunohistochemical staining
confirmed the presence of placental CMV
infection.
Conclusion: Congenital CMV infection may
present in an unusual manner. The practitioner
must maintain a high index of suspicion for con-
genital infection.
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GenProbe Pace II for gonorrhea and
chlamydia
Jeanna M. Piper MD, William A. Peairs MA,
Rochelle N. Shain PhD, Sondra Perdue DrPH and
Jane D. Champion PhD
Department of Obstetrics and Gynecology,
UTHSC-SA, San Antonio, TX
Objectives: To comparethesensitivity and speci-
ficityofAbbottLCXwiththoseofGenProbePace
II for the detection of cervical infection with
Neisseria gonorrhea (GC) or Chlamydia trachomatis
(CT) in high-risk women.
Study design: 265 consecutive women under-
going testing by cervical swab for GC and CT
using the GenProbe Pace II (collected first) had an
additional cervical swab obtained for performance
of the Abbott LCX (collected after the GenProbe
sample). Both assays were run according to the
manufacturer’s standard protocols.
Results:Thirty-fourwomenhadapositivetest for
CT (12.8%) and 15 women had a positive test for
GC (5.7%). CT was detected by LCX in 31/34
(91.2%) and by GenProbe in 24/34 (70.6%) with
concordance noted in 21 cases (61.8%), only
LCX+ in 10 (29.4%) and only GenProbe+ in
3 (8.8%). GC was detected by LCX in 14/15
(93.3%) and by GenProbe in 14/15 (93.3%) with
concordance noted in 13 cases (86.7%), only
LCX+ in 1 (6.7%) and only GenProbe+ in 1
(6.7%). Six women had a positive test for bothGC
and CT with 3 cases concordant, 1 GC+ by
GenProbe only, 1 CT+ by GenProbe only and
1 CT+ by LCX only.
Conclusions: The use of LCX technology using
cervical samples increased the detection of CT by
30% in a cohort of high-risk women, but did not
impactonthedetection ofGCinthesame popula-
tion. Increased use of DNA amplification tech-
niques in clinical practice will result in improved
detection and potentially reduced morbidity
owing to the opportunityfor administering earlier
therapy for cervical infections caused by CT.
Intracellular interleukin-4 (IL-4) cytokine
production in HIV+ and HIV- women
Arlene Bardeguez MD, Bart Holland PhD,
Thomas Denny BS, Madeline Sutton MD,
Zeneida Garcia BS, Janet Stein BS and
Paul Palumbo MD
New Jersey Medical School, Newark, NJ
Objective:Toevaluate intracellular interleukin-4
(Il-4) production in CD4 and CD8 lymphocytes
among HIV-infected pregnant women and sero-
negative counterparts.
Studydesign:Sixty-onewomenwereenrolledin
the study (31 HIV+, 30 HIV-) and after obtaining
informed consent study visits were scheduled
every trimester and postpartum for the pregnant
women, while the non-pregnantwomen had only
one evaluation. HIV-infected women were staged
based on the adult adolescent CDCP classification.
At each study visit participants had peripheral
whole blood drawn to analyze for (1) lymphocyte
profile, (2) measurement of intracellular cytokine
production and (3) viral load. Medical records
were reviewed to abstract information regarding
HIV medications and medical/obstetrical compli-
cations. Fischer’s exact test, and Rank sums were
used for analysis.
Results: HIV-infected women were more likely
to be older (28 ± 7 yrs vs. 24 ± 5 yrs; p = 0.04) and
have a past or present history of substance use
(p = 0.0001). There were significantly lower CD4
counts and higher CD8 counts among HIV-
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HIV+ HIV- p
Time 0
Cd4
Cd4-IL4
Cd8
Cd8-IL4
Time 3
Cd4
Cd4-IL4
Cd8
Cd8-IL4
463 ± 270
6.5 ± 2.1
913 ± 349
4.8 ± 2.7
482 ± 239
6.7 ± 2.8
1141 ± 919
3.2 ± 1.9
714 ± 262
4.3 ± 1.8
436 ± 124
4.3 ± 1.2
892 ± 262
4.7 ± 2.9
617 ± 235
3.0 ± 2.2
0.04
0.030
0.0005
0.82
0.002
0.029
0.01
0.80
Table 1 Levels of Cd4 and Cd8 cells, and interleukin-4
(IL-4) in theminfected women compared to seronegative
counterparts (Table1). IL-4 levels in CD4 cells
were higher among HIV-infected women during
pregnancy and postpartumbut productionof IL-4
in CD8 cells was no different between HIV-
positive and negative women. Intracellular IL-4
productionwas correlated with disease stage, CD8
counts and viral load.
Conclusion: Intracellular IL-4 production was
primarily observed only within CD4 cells in our
cohort. There was a higher production of IL-4
among HIV-infected women through pregnancy
and postpartum. Pregnancy could further enhance
the balance toward a TH-2 response elicited by
HIV infection.
Vaginitis due to Candida krusei:
epidemiology, clinical aspects, and therapy
Shivani Singh MD, Jack D. Sobel MD, Pallavi
Bhargava MD and Jose Vazquez MD
Objectives: To study the epidemiology, clinical
aspects, and therapy of C. krusei vaginitis.
Study design: Retrospective chart review of 10
women with C. krusei in 25 vaginal samples over
the last 15 years with MIC testing and molecular
typing.
Results: The ages of the women in the study
group ranged from 32 to 63 years, with a mean of
44 years; eight of the ten were Caucasian. Seven of
the women were pre-menopausal, of whom four
had had previous bacterial vaginosis. The patients
frequently had chronic, refractory vulvovaginal
signs and symptoms, which were otherwise indis-
tinguishable from vaginitis due to other yeasts.
These patients had received multiple antimycotics
including fluconazole and miconazole. On wet
films eight of the ten showed budding yeast only
and two had yeast and hyphae. Three of the ten
had a second consecutive yeast species while two
had a coexistent yeast species. The MIC90 of
fluconazole was > 64 mg/ml, that of miconazole
was 4 mg/ml; the most active azole was
clotrimazole, with a MIC90of0.25 mg/ml.Three
out of four patients treated with clotrimazole and
four out of five treated with boric acid responded
clinically and mycologically. Two dominant
karyotypes were identified on CHEF; no major
karyotypechangewasseen in successive samples of
the same patient, confirming vaginal relapse in
these refractory cases.
Conclusions: C. krusei is a rare but important
cause ofvaginitis in women over 30 years ofage. It
is highly resistant to fluconazole and miconazole.
Therecommendedtreatment isprolongedtherapy
with clotrimazole or boric acid.
References
1. Sobel et al. Vaginitis due to Saccharomyces
cerevisiae: epidemiology, clinical aspects, and
therapy. CID 1993;16:93–9
2. Vazquez et al. Comparison of REA vs.
pulsed-field gradient gel electrophoresis as a
typing system for Torulopsis glabrataand Candida
species other than C. albicans. J Clin Microbiol
1993;8:2021–30
The effect of temperature on the
bactericidal properties of 10%
povidone-iodine solution
Michael P. Leung MD, Karen D. Bishop BS and
Manju Monga MD
DepartmentofObstetrics, GynecologyandReproductive
Sciences, University of Texas Houston Medical School,
Houston, TX
Objectives: Ten percent povidone-iodine (PVI)
is commonlyusedas abactericidalsolutionpriorto
amniocentesis; the use of warm PVI may increase
patient comfort. However, manufacturers suggest
that PVI be stored at room temperature, and the
effect of warming on its bactericidal properties is
not known. The objective of this study was to
determine the effect of warming on the bacteri-
cidal properties of 10% PVI.
Methods: In vitro experiments were conducted in
25°C (room temperature) and 32°C water baths,
the latter temperature being maintained by the use
of an ultrasonic gel warmer. Nine ml of PVI was
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ature and 1 ml of bacteria (107 organisms/ml
S. aureus, Enterococcus, E.coli, group B Streptococcus)
was added. After 0.25, 0.5, 1, 2, 4 and 8 minutes,
1 ml samples were removed and added to 4 ml
0.5% sodium thiosulfate (to neutralize the iodine
and interrupt bactericidal action). The number of
viable organisms was determined by plating 0.1 ml
samples on TSA plates. Plates were incubated at
370C for 24 hours and CFUs counted. For in vivo
experiments in 20 volunteers, a 9 cm2 area of the
dorsum of each hand was cultured and then wiped
for 15 seconds with PVI at 25°C or 32°C. Each
hand was re-cultured using TSA plates (after 48
hourculture). The ability to kill more than 99% of
organisms after 15 seconds using PVI at each
temperature was compared. The Mann–Whitney
U test was used where appropriate and a p value
< 0.05 was considered significant.
Results: In vitro, PVI was bactericidal against
E. coli, S. aureus, Enterococcus and group B Strepto-
coccus within 0.25 minutes at both 25°C and 32°C
with median bacterial growthof no CFU/plate for
each bacterium studied (three replicates at each
temperature). Median bacterial growth from skin
was6CFU/plate (range0tomore than 100). After
wiping with PVI at 25°C and 32°C, median
bacterial growthwas 1 CFU/plate (range 0–3) and
0 CFU/plate (range 0–4), respectively (NS).
Conclusion:PVIisaseffectiveat32°Casat25°C.
The use of PVI at 32°C should be considered in
procedures performed without anesthetic.
Cellulose sulfate inhibits Gardnerella vaginalis
and other anaerobes associated with
bacterial vaginosis
Jose A. Simoes1,2, Lourens J. D. Zaneveld1,
Alla Aroutcheva1, Calvin J. Chany II1,
Robert A. Anderson Jr1, Donald P. Waller3 and
Sebastian Faro4
1DepartmentofObstetricsandGynecology,RushMedi-
cal College,Chicago, IL; 2Departmentof Obstetrics and
Gynecology,StateUniversity ofCampinas,SP,Brazil;
3Department of Pharmaceutics and Pharmacodynamics,
College of Pharmacy, University of Illinois at Chicago,
Chicago, IL; 4Department of Obstetrics and Gyneco-
logy, The University of Texas Health Science
Center-Houston,andThe Woman’sHospital ofTexas,
Houston, TX
Introduction: A high molecular weight sulfated
polysaccharide(approximately1900kDa)cellulose
sulfate (H-CS) is a new vaginal antimicrobial con-
traceptive compound that can inhibit the replica-
tion of human immunodeficiency virus type 1,
herpes simplex virus, and the growth of Neisseria
gonorrhoeae and Chlamydia trachomatis but not the
growth of lactobacilli. It is important that vaginal
microbicides do not alter the endogenous vaginal
microflora resulting in conditions such as bacterial
vaginosis (BV).
Objectives: To evaluate whether H-CS can
inhibit the in-vitro growth of Gardnerella vaginalis
and other anaerobic bacteria associated with BV.
Study design: Eight clinical isolates from patients
with BV were used for this preliminary study,
including strains of G. vaginalis, Prevotella bivia,
Peptostreptococcus asaccharolyticus and Peptostreptococcus
anaerobius. Samples of H-CS were serially diluted
in a range between 10 mg/ml and 0.125 mg/ml.
The macrodilution broth method was performed
according to National Committee for Clinical
Laboratories Standards to evaluate the effect of
H-CS on the growth of anaerobic bacteria. The
zone of growth-inhibition in HBT agar plate was
used to evaluate its effect on G. vaginalis growth.
Results: A dose-dependent growth-inhibition
effect of H-CS was foundagainst all G. vaginalis, as
well as P. bivia, P. asaccharolyticus and P. anaerobius
clinical isolates.
Conclusions: These preliminary results suggest
that vaginally applied H-CS may inhibit the
growth of BV-associated organisms and support
the use of H-CS as a safe vaginal microbicide.
Furtherstudiesneedto beperformedto confirmits
clinical efficacy.
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HIV-infection
Deborah Cohan MD, Abner Korn MD and
Joel Palefsky MD
Objectives: To investigate the role of HPV and
determine the HPV subtypes involved in vulvar
intraepithelial neoplasia (VIN) among HIV-
infected and uninfected women.
Study design: A case-control study was per-
formed among HIV-positive and HIV-negative
women diagnosed with VIN. Medical charts were
abstracted for age, tobacco use, and primary vs.
recurrent VIN. The specimens were graded as
VIN1,VIN2,orVIN3,utilizingstandardcriteria.
Polymerase chain reaction (PCR) was performed
on DNA preparations from stored vulvar speci-
mensusingconsensusHPV L1 primers. Specimens
were then probed for 39 different HPV subtypes.
Variables were analyzed using the c2 test, Fisher’s
exact test, or t test, as appropriate, using
EpiInfo2000 (CDC, Atlanta, GA).
Results: Thirty-two HIV-positive cases and 20
HIV-negative controlswere includedin thestudy.
There were no significant differences in age,
primary vs. recurrent nature of VIN, VIN grading
or tobacco use between cases and controls. There
was no difference in the prevalence of multiple
HPV types or unusual HPV types in cases (9%)
versus controls (10%). 63% of HIV-positive
women with VIN had no detectable HPV as com-
pared to 40% of HIV-negative women.
Conclusions: There was very low recovery of
HPV overall, but particularly in HIV-infected
women. This may be owing to unique HPV types
not found on the available probes. Our finding of
3 cases among HIV-infected women in which
HPV was present but could not be further
sub-typed supports this hypothesis. On the other
hand, VIN could be caused by an etiology other
than HPV in HIV-infected women. Further
studies are necessary to investigate the natural
history of HPV in HIV-infected women and to
examine possible atypical HPV types and co-
factors in the development of vulvar dysplasia.
Phage infection of lactobacilli: prevalence
and host ranges
L. Tao1, S. I. Pavlova1, A. O. Kiliç1,2,
V. S. Ocana3, M. E. Nader-Macías3,
J. A. Simoes4, E. E. Castro5and J. S. So6
1University of Illinois at Chicago, USA; 2Karadeniz
Technical University, Trabzon, Turkey; 3CERELA,
CONICET, Argentina; 4State University of
Campinas, Brazil; 5University of Concepcion, Chile;
6Inha University, S. Korea
Objectives: Since a reduction of vaginal lacto-
bacilli is associated with bacterial vaginosis, it is
important to study phages that infect lactobacilli.
The aims of this study were to determine the
species of phages and lactobacilli in the human
vagina, theprevalence of phage infection in differ-
ent populations,and thehost ranges ofthese infec-
tive phages.
Study design: Vaginal samples were collected
fromreproductive-agedwomeninTurkeyandthe
USA to determine phage types. Vaginal samples
from women of other countries, including Brazil,
Argentina, Chile, China, India and S. Korea,were
analyzed for Lactobacillus species and for establish-
ing a phylogenetic tree based on their 16S rRNA
sequences. Finally, chromosomal DNAs from
these lactobacilli were probed with DIG-labeled
genomic DNA from two representative type
phages, kc5a and TL34, to determine the preva-
lence of phage infection and the host ranges.
Results: Sixty-seven phages were isolated from
the vaginal lactobacilli of 209 women in the USA
and Turkey, among which two major phage types
were identified. Out of 450 vaginal lactobacilli
isolated from women from different countries, 35
representative strains were selected for species
determination. Their 16S rRNA gene sequences
were used to establish a phylogenetic tree. Most
lactobacilli belonged to three major species,
L. crispatus, L. jensenii, and L. gasseri. Minor
species included L. fermentum, L. vaginalis, L.
mucosae, L. paracasei, L. rhaminosus, and two new
phylotypes. None of the vaginal Lactobacillus spe-
cies were the same as those found in food. Phage
Abstracts
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY 171infection was not limited to specific Lactobacillus
species. Lactobacilli infected by phages were com-
mon among women in the cities of the USA,
Turkey, Brazil and Chile, but rare among women
in South Korea and northern Argentina.
Conclusions: Two major phage types and multi-
ple Lactobacillus species were identified in the
vagina of women. Phage infection of lactobacilli
did not appear to be species specific. The preva-
lence of phage infections varied significantly
among women in different areas.
Ampicillin-resistant Escherichia coli in
gestational pyelonephritis: increased occur-
rence and association with the colonization
factor DR adhesin
Audrey Hart BA1, Bogdan J. Nowicki MD, PhD1,2,
Barbara Reisner3, Edyta Pawelczyk1,
Pawel Goluszko MD, PhD1, Petri Urvil PhD1,
Garland Anderson MD1 and Stella Nowicki DDS1,2
1Division of Infectious Diseases, Department of Obstet-
rics & Gynecology, 2Department of Microbiology &
Immunology and 3 Department of Pathology, The
University of Texas Medical Branch at Galveston
Summary: Weevaluated thepatternofampicillin
resistance and possible association with virulence
factors of 78 Escherichia coli isolates from 78
pregnant women with pyelonephritis. The occur-
rence of ampicillin resistance was significantly
higher among pyelonephritis isolates (46%) than
that reported in 1985 (22%). Resistance was found
more frequently during the first (60%) and third
(53%) trimester than during the second (33%)
trimester. Of all dra+ E. coli isolates, 75% were
ampicillin-resistant, while dra+ of O75 serotype
E. coli accounted for 87% of ampicillin-resistant
strains. Thesignificantincrease of ampicillin resist-
ance among gestational pyelonephritis E. coli and
association with the dra gene cluster encoding col-
onization and invasive capacity may warrant fur-
ther study involving obstetrics and neonatal wards,
with the last being at the highest risk for potential
problems.
Serum complement activity during menses
as a risk factor for gonococcal pelvic
inflammatory disease
Audrey Hart BA1, Petri Urvil PhD1, Bodgan
Nowicki MD, PhD1,2and Stella Nowicki, DDS1,2
1Department of Obstetrics and Gynecology, and
2Department of Microbiology and Immunology,
The University of Texas Medical Branch at Galveston,
Texas, 77555-1062
Objective: Symptoms of gonococcal pelvic
inflammatory disease usually occur at the onset of
menses. Our recent study showed that the bacteri-
cidal activity of normal human serum (NHS)
decreased during menses. Complement C1q plays
a crucial role in both bactericidal activity and
gonococcalvirulence. Therefore we evaluated the
serum complement C1q level and C1q binding to
Neisseria gonorrhoeae and compared them to com-
plement activity pre-, during and post-menses.
Design: Serum from four female subjects of
reproductive age without a prior history of gono-
coccal infection was obtained from blood drawn
pre-, during and post-menses. Serum C1q level
and complement activity were measured through-
out the menstrual cycle. The interaction of C1q
with N. gonorrhoeae cells was analyzed in
immunoblots.
Results: The results indicated that complement
activity decreased during menses, corresponding
to reduced bactericidal activity of the serum.
Complement and bactericidal activity were
inversely related to serum levels of C1q and C1q
interaction with N. gonorrhoeae.
Conclusion: Decreased complement activity
may account for the reduced bactericidal activity
of serum during menses, while increased C1q
interaction with N. gonorrhoeae may enhance
gonococcal virulence during the onset of menses.
These results also suggest thatcomplement activity
and complementcomponentsmay beregulated by
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increased C1q binding combined may predispose
women to a higher risk of developing gonococcal
pelvic inflammatory disease during menses.
Placental histopathology of congenital
syphilis correlated to pregnancy outcome
Jeanne S. Sheffield MD, David W. I. Fong MD,
Pablo J. Sanchez MD, George D. Wendel Jr MD,
Linda R. Margraf MD, Donald D. McIntire PhD
and Beverly Barton Rogers MD
Departments of Obstetrics and Gynecology, and
Pediatrics and Pathology, University of Texas
Southwestern Medical Center, Dallas, TX
Objective: To evaluate the contribution of
placental histopathology to the diagnosis of con-
genital syphilis.
Study design: The study was a retrospective
cohort analysis from January 1 1986 to December
31 1998. Women who delivered with a reactive
serologyforsyphilisandwhohadreceived noprior
treatment were evaluated and clinically staged.
Infants were examined and underwent long-bone
radiographs and laboratory testing. In addition,
infants had specific IgM immunoblotting, poly-
merase chain reaction (PCR) and/or rabbit
infectivity testing. Placental histopathology was
performed and the findings correlated with the
outcome of pregnancy.
Results: Sixty-seven women admitted for
delivery had reactive syphilis serologic testing and
placentas available for review. There were 33
(49.3%) stillborn infants and 18 (26.9%) liveborn
infants with congenital syphilis, 15 (22.4%) un-
infected liveborn infants and one uninfected still-
bornfetus. There were no differences between the
groupswith regard to demographiccharacteristics,
prenatal care or stage of syphilis. Stillborn infants
were more likely to delivery preterm (p < 0.001).
Controlling for gestational age, histopathology
revealed necrotizing funisitis, villous enlargement
and acute villitis associated with congenital syphi-
lis. Erythroblastosis was more common in stillborn
infants with congenital syphilis than liveborn
infants with or without congenital syphilis
(OR 16; 1.6–69). Using physical exam, laboratory
analysis and placental histology, 89% and 97% of
liveborn and stillborn infants with congenital
syphilis, respectively, were detected compared
with 67% and94%usingphysicalexam andlabora-
tory analysis alone.
Conclusions: Histopathologic examination of
the placenta is a valuable adjunct to the standard
criteria used to diagnose congenital syphilis.
Efficacy of common antiretroviral regimens
during pregnancy
James B. Hill MD, Jeanne S. Sheffield MD and
George D. Wendel Jr MD
DepartmentofObstetrics andGynecology, University of
Texas Southwestern Medical Center, Dallas, TX
Objective: To compare the efficacy of common
antiretroviral regimens in pregnant women in
decreasing the maternal viral burden.
Methods: A retrospective chart review of HIV-
infected women was performed and analyzed with
respect to treatment regimen between May 1997
and January 2001. Plasma HIV-1 viral burden and
CD4 count were analyzed at the first prenatal visit
and at delivery. The interval from initiation of
medication to delivery, infantoutcomesand mode
of delivery were noted and statistical analysis was
performed using the ANOVA and Kruskal-Walis
test.
Results: Study criteria were met and results were
available for 121 women over the 3.5-year time
period. Thirty-one women (25.6%) received
combivir alone, 77 (63.6%) received combivir
and a protease inhibitor (PI), and 13 (10.7%)
received combivir and a non-nucleoside reverse
transcriptase inhibitor (NNRTI). Table 1 lists
the outcomes of interest in the 3 treatment
regimens.
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Combivir
(n = 33)
Combivir + PI
(n = 77)
Combivir + NNRTI
(n = 13) p value
HIV-1 viral load (copies/ml)
Baseline, median (range)
Delivery, median (range)
< 1000 copies/ml (%)
< 400 copies/ml (%)
663 (< 400–56 451)
< 400 (< 400–23 302)
26 (78.8)
23 (69.7)
5175 (< 400–173 000)
< 400 (< 400–48 797)
65 (84.4)
52 (67.5)
440 (< 400–28 458)
< 400 (< 400–2334)
11 (84.6)
10 (76.9)
NS
NS
NS
NS
CD4 count (per mm3)
Baseline, mean + SD
Delivery, mean + SD
Interval from baseline to
delivery (days)
515 ± 265
622 ± 344
210 ± 194
410 ± 227
496 ± 245
160 ± 76
527 ± 225
617 ± 263
156 ± 57
0.005
NS
NS
Table 1 Viral load at baseline and delivery
Five patients underwent cesarean delivery for high
viral loads;noinfantsinthiscohortdevelopedHIV
infection
Conclusion: Combination antiretroviral therapy
reduces plasma HIV-1 viral burden to less than
400 copies/ml in approximately 80% of
HIV-infected pregnant women. Utilizing an
aggressive anti-retroviral regimen reduces viral
loads, and potentially decreases the rate of vertical
HIV-1 transmission, allowing most women to
undergo a vaginal delivery.
Evaluation of clinical methods for diagnos-
ing bacterial vaginosis
Robert E. Gutman MD, Jeffrey Blume PhD,
Walter Heber MS, Jeffrey F. Peipert MD, MPH
Women & Infant’s Hospital, Brown University
Medical School, Providence, RI
Objectives: Current clinical criteria for the diag-
nosis of bacterial vaginosis (BV) include (1) a thin,
homogeneous discharge, (2) pH > 4.5, (3) the
release ofamineodorwiththeadditionofbase,and
(4) thepresenceofcluecells onmicroscopic evalu-
ation of saline wet prep.A positive clinical diagno-
sis is made when three or more criteria are present.
The objective of this study was to determine if the
clinical criteria can be simplified without signifi-
cant loss of diagnostic sensitivity or specificity.
More specifically, we believe that the presence of
two criteria may be as accurate as the presence of
three or more of the clinical criteria
Study design: The study was a cross sectional
analysis of fifty-nine subjects enrolled in clinical
research studies andwomenwhowereundergoing
a vaginal exam in the primary care clinic. All four
clinical criteria were collected as well as the
FemExam card. A Gram stain was performed for
a definitive diagnosis. Calculations of sensitivity,
specificity and their respective 95% confidence
intervals (CI) are presented for each individual
criterion and combinations of clinical criteria
(Table 1).
Sensitivity Specificity
Vaginal discharge
pH > 4.5
Positive amine
odor
Clue cells present
(> 20%)
Elevated pH and
amine odor
Elevated pH and
clue cells
Clue cells and
amine odor
Amsel’s criteria
(> 3 of 4 criteria)
0.76 (0.65–0.89)
0.86 (0.77–0.95)
0.77 (0.66–0.88)
0.73 (0.62–0.84)
0.73 (0.62–0.84)
0.68 (0.56–0.80)
0.68 (0.56–0.80)
0.76 (0.65–0.87)
0.53 (0.40–0.66)
0.81 (0.71–0.91)
0.95 (0.89–1.00)
0.92 (0.85–0.99)
0.97 (0.93–1.00)
0.97 (0.93–1.00)
0.97 (0.93–1.00)
0.97 (0.93–1.00)
Table 1 Sensitivity and specificity of the criteria for BV,
alone or combined (n =59; 95% CI in brackets)Results: The results are presented in Table 1.
Conclusions: From this initial analysis webelieve
that the combination of two clinical criteria can
perform as well as 3 or more (Amsel’s) criteria.
After further recruitment, ROC analysis will be
performed to confirm our preliminary findings.
Cervical manipulation and membrane
‘stripping’ associated with stillbirth caused
by group B Streptococcus and other
perinatal pathogens: cervical membrane
disruption syndrome (CMDS)
C. A. Stamm MD, L. A. Bishop BA,
J. A. McGregor MD, CM, J. G. McFee MD and
M. Perach
Denver Health Medical Center, University of
Colorado School of Medicine, Denver, Colorado, and
Pasadena, California
Objective: We present five cases in which
cervical manipulation (‘membrane stripping’)
intended to facilitate labor preceded perinatal
sepsis and stillbirth caused by invasive Group B
Streptococcus (GBS) as well as other perinatal
pathogens.
Study design: Each case presented with similar
salient features – term gestation in a previously
healthy pregnancy, elective or non-urgently
indicated promotion of labor and digital cervical
manipulation.
Results: In each case there was rapid labor with
placental findings of histologically severe intra-
uterine infection or funisitis, often in the absence
of classical clinical criteria of chorioamnionitis
(CAM). Onewoman suffered observed fetal death
due to overwhelming fetal GBS sepsis 15 hours
after‘membranestripping’toinducelaboratterm.
Conclusion: These cases support prior evidence
that cervical manipulation is associated with
translocation of vaginal microbes into the lower
uterus1. The incidence of such presumably rare
occurrences can only be established in large
prospectiveepidemiologicstudies.Wesuggest that
our case definition be utilized in future studies.
Clinicians may reconsider elective cervical manip-
ulation in patients with cervical vaginal infection
orcolonizationwithpotentialperinatalpathogens,
including GBS, and should identify and treat
cervical infection or consider a GBS-specific
chemprophylaxis prior to membrane stripping.
Reference
1. McGregor, Farkouh. IDSOG 1998;89
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Chorioamnionitis
(n = 17)
No chorioamnionitis
(n = 17) p value
Total nuclei, median (range)
Total apoptotic nuclei, median (range)
Percent positive nuclei, median (range)
520 (323–734)
21 (3–68)
4.3 (0.5–9.3)
543 (378–735)
9 (1–56)
1.7 (0.2–1.5)
NS
p = 0.0004
p < 0.0001
Table 1 Number of nuclei and apoptotic nuclei in chorion laeve in patients with and without chorioamnionitis
Apoptosis in the chorion laeve of term
patients with histologic chorioamnionitis
A. P. Murtha1, V. D. Dew1 and R. Bentley2
Departments of Obstetrics and Gynecology1 and
Pathology2, Duke University Medical Center,
Durham, NC
Objective: In a pilot study of term fetal mem-
branes from surgical pathology specimens, we
previously reported increased apoptosis in the
chorion laeve of patients with histologic
chorioamnionitis. The objective of this investiga-
tion was to confirm our previous results by deter-
miningtheextentofapoptosisinthechorionlaeve
in term patients with and without histologic
chorioamnionitis.
Study design: 134 fetal membrane rolls were
collected immediately after delivery remote from
the rupturesite and within 2 cm of the edge of theplacenta. Samples were fixed in formalin, embed-
ded in paraffin and examined for evidence of
histologicchorioamnionitisbyasinglepathologist.
All membrane rolls were stained for apoptosis
using the TUNEL method (Oncor, Gaithersburg,
MD). The extent of apoptosis was quantified by
counting the number of apoptotic nuclei in the
chorionlaeve relative to thetotalnumberofnuclei
in 5 randomly chosen high-powered fields.
Samples were divided into those with and without
histologic chorioamnionitis. Clinical and demo-
graphic data were collected by chart abstraction
and data were analyzed by the Mann–Whitney U
test with significance defined as p < 0.05.
Results: There were no significant differences
in maternal age, race, insurance status, cesarean
delivery or gestational age at delivery between the
two groups. Chorion laeve of fetal membranes
from term patients with histologic chorio-
amnionitis had significantly more apoptotic nuclei
than those without chorioamnionitis (Table 1).
Conclusions: These data confirm the finding of
our pilot investigation that apoptosis is accelerated
in the chorion laeve of term subjects with
histologic chorioamnionitis. Intra-amniotic infec-
tionorinflammation may beassociated withaccel-
erated cell death in this important cell layer.
Additional studies are needed to determine the
clinical significance of this finding.
Primary cultures of endocervix and
ectocervix demonstrate unique cytokine
secretion patterns
Michael A. Nicolazzo BS, Jean J. Latimer PhD,
Crystal M. Kelly BS and Deborah L. Draper PhD
Magee Women’s Research Institute, Department of
Obstetrics and Gynecology School of Medicine,
University of Pittsburgh, Pittsburgh, PA 15213
Objective: The study of early epithelial cytokine
responses during infection is an emerging field of
mucosal immunology. The endocervix has not
been successfully studied and traditional models of
female genital tract infections have relied on trans-
formed or immortalized cells in tissue culture1.
The aim of this study was to design an in vitro
endocervical primary tissue culture model which
maintains the relevant structures, epithelial
polarity, extracellular matrix contact and long-
evity, and which can be used for comparison with
ectocervical cultures for early cytokine responses.
Study design: Fresh tissue (1–2 cm2) from the
endocervix and ectocervix was taken from
premenapausal women undergoing hysterectomy
(n = 4) for non-infectious or non-cancer causes.
Tissues were processed using the Latimer method
(patent pending2). Cells were cultured with the
novel MWRI epithelium medium and established
on extracellular matrix (Matrigel). Digital images
of growth patterns and cellular morphology were
captured every 2–4 days and correlated to secreted
levels of IL-1b, IL-6, IL-8, IL-10 and SLPI as
measured by enzyme linked immunosorbent assay
(ELISA).
Results: Endocervical epithelium grew well,
could be sub-cultured for at least 4 passages, and
formed glandular-like epithelial structures with
connectingchannelsonalayer offibroblasts(about
days 14–21). Ectocervix formed typical multi-
layered epithelial cells on fibroblasts (days 15–18).
Cytokine release patterns were initially modulated
and then stabilized out to 120 days in culture.
Comparisons of cytokine levels in endocervical
with those in ectocervical culture supernatants
demonstrated unique secretion patterns with
significant differences (p < 0.05).
Conclusions: Primary genital epithelial cultures
of endocervix and ectocervix can be established
with the MWRI method and can be used for the
measurement of early, relevant cytokine response
patterns.
References
1. Fichorova, Anderson. Biol Reprod 1999;6:
508–14
2. Latimer et al. 2000; U.S. Patent # 6074874
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mothers with an intrauterine device (IUD)
during pregnancy: is there an ‘IUD baby
syndrome’?
J. A. McGregor, C. Stamm, K. Davis and
J. E. Berg
Denver Health Medical Center, Denver, CO; New
York, NY; and University of Colorado School of
Medicine, Denver, CO
Objective: The aim of this study was to describe
and analyze persistent neurologic impairment(s)
among five adult offspring conceived and gestated
with an intrauterine device (IUD) in place during
pregnancy. Perinatal white matter damage
(WMD) associated with intrauterineinflammation
is hypothesized to be a possible intermediate
factorbetween thepresenceofanIUD duringges-
tation and persistent neurologic/neurobehavioral
disorders1.
Study design: We analyzed developmental find-
ings and neurologic assessments in a convenience
sample of five adults who had been exposed to an
IUD during their gestation.
Results: The subjects were a convenience sample
of young adults exposed to an IUD during gesta-
tion, all of whom were between 26 and 29years of
age; four were female. Each subject was associated
with the presence of a Dalkon Shield which could
not be removed or was intentionally left in place
during pregnancy. Preterm birth and premature
rupture of membranes were common (three out
of the five cases) as was maternal febrile
morbidity/sepsis (two outof five). Spastic cerebral
palsy (CP) occurred in two of the five. Develop-
mental delay and academic failure were present in
all cases as were deficiencies in spatial orientation.
Clinical diagnosis and treatment of severe depres-
sion (3/5), anorexia (2/4 females), and obses-
sive-compulsive disorder (2/5) were common.
Thesubjectswere consistentlydescribed as lacking
‘common sense’, socially isolated and ‘clumsy’.
Only one suffered seizures.
Conclusion: We describe five individuals
demonstrating persistent, neurologic and/or
neurobehavioral abnormalities during childhood
and adulthood who were exposed to a Dalkon
Shield IUD during gestation. Further studies are
required to confirm these putative associations of
abnormalities with the presence of an IUD during
gestation and discover possible mechanisms for
them. The possible existence of a so-called ‘IUD
baby syndrome’ may prompt care providers to
ensure the removal of an IUD duringgestation or,
alternatively, to scrupulously identify and treat
reproductive tract infections during pregnancy
with a retained IUD.
Reference
1. Damman O, et al. Curr Opin Pediatr 2000;12:
99–104
Imiquimod 5% cream is safe and effective
in female patients with external genital
warts: Results of an open-label multi-center
trial
Michel Fortier, MD
University of Laval, Quebec City, Quebec
Objective: To determine the safety and efficacy
of imiquimod 5% cream, an immune response
modifier, in the treatment of external genital/
perianal warts in female patients. Imiquimod,
whichhas antiviral properties, elevates thelevels of
cytokines such as interferon-alpha resulting in
stimulation of cell-mediated immunity.
Studydesign:Females withexternal genitalwarts
appliedimiquimod5%cream 3times perweek,for
up to 16 weeks. Patients who cleared their warts
entered a 6-month follow-upperiod.Iftheir warts
recurred, or new warts developed, patients could
be re-treated for up to 16 additional weeks.
Patients who experienced partial clearance in the
initial treatment period could enter a second con-
secutive16-week treatment period.Patientsinthis
groupwhocleared theirwartswerealso monitored
for 6 months.
Results: A total of 410 female patients, from 114
clinicsites in20countriesparticipatedinthisstudy.
Complete clearance was observed in 59.3% of
patients (intent-to-treat analysis) in the initial
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in the second consecutive treatment period. The
overall clearance rate was 65.4%. In a treatment
failures analysis that excluded those patients who
discontinued for reasons unrelated to safety or lack
of efficacy, the clearance rate was 75.4%. Only
5.4%and15.3%ofpatientsexperiencedrecurrence
of warts in the 3- and 6-month follow-up periods,
respectively, resulting in sustained clearance rates
(patients who cleared during treatment and
remained clear at the end of the follow-up period)
of 55.6% and 45.8%. For patients who re-applied
imiquimod for up to an additional 16 weeks after
experiencing wart recurrence, the clearance rate
was 67.7% (21/31).
Local skin reactions in the majority of patients
were of mild to moderate severity; the most
frequentlyreportedwaserythema,whichoccurred
in 64% of patients. The frequency of local skin
reactions decreased from initial to subsequent
treatment periods.
Conclusion: Imiquimod 5% cream is a safe and
effective treatment for external genital warts in
females for up to 16 weeks and continues to
provideawell-tolerated benefittothosetreated for
up to 32 weeks.
Determination of Ureaplasma urealyticum
biovars in post-partum endometritis (PPE)
Chaim Walter, Horowitz Shulamith, Ingel Frida,
Evinson Bela and Mazor Moshe
Department of Obstetrics and Gynecology and
Department of Microbiology and Immunology, Soroka
University Medical Center, Ben-Gurion University,
Beer-Sheva, Israel
Objective: There are two biovars (parvo and
T960) comprising 14 serovars of U. urealyticum
(1, 3, 6, 14 and 2, 5, 8, 9–13, respectively). Some
serovars have been shown to be associated with
disease syndromes (prematurity, recurrent abor-
tions, urethritis, infertility etc.). Our objective was
to determine whether there is a predominanceof a
certain biovar of U. urealyticum in postpartum
endometritis (PPE).
Study design: U. urealyticum biovars as well as
anti-ureaplasma antibodies were determined in a
group of patients who had previously presented
with PPE and who were culture positive for
U. urealyticum.
Results: We have previously found that there is a
significant difference between women with PPE
and controls regarding level of colonization (cfu).
Inalargerstudywefoundthat26outof67(38.8%)
of culture positive PPE patients had very high
levels of U. urealyticum (> 105cfu/ml) compared to
5outof 30(16.7%) in thecontrolgroup(puerperal
women without PPE) (p = 0.03). Determination
of U. urealyticum biovars revealed thatthere was no
significant difference between the PPE patients
and the controls. Neither was there a statistically
significant difference between the study and the
control groups regarding anti-ureaplasma anti-
bodies (30% vs 18%, respectively).
Conclusions: The involvement of U. urealyticum
in the development of puerperal morbidity is
dependent on the colonization rate in the cervix
(> 105 cfu/ml), and not merely on its presence or
absence in a culture. The prevalence of the
U. urealyticumbiovars in thePPE groupwas similar
to that in the control group.
Antimicrobial resistance alert among
anaerobes: comparison of obstetric-
gynecological and intra-abdominal (IA)
isolates
K. E. Aldridge PhD and D. Ashcraft BS (MT)
LSU Health Sciences Center, New Orleans, LA
Objectives: Recent studies have shown that
patients who develop bacteremia with anaerobes
(particularly of the B. fragilis group) (Bfg) and
are receiving inappropriate empiric antimicrobial
therapyhaveasignificantly highermortalityrate1,2.
In a recent in vitro study we compared the suscept-
ibility rates of similar groups of anaerobes from
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abdominal (IA) sources.
Study design: Using a broth microdilution
method as recommended by the National
Committee for Clinical Laboratories Standards
(NCCLS), susceptibility MIC data were deter-
mined for seven antimicrobials. 112 Ob-Gyn and
346 IA isolates were tested;46% and 81% were Bfg
isolates, the remaining being isolates of Prevotella
(Prev), Fusobacterium (Fuso), Porphyromonas (Por),
and Peptostreptococcus (Pept).
Results: Against both Ob-Gyn and IA the most
active agents were piperacillin/tazobactam (P/T),
metronidazole (MET), and imipenem (IMP) (one
Pept. isolate from each source was resistant to
MET).OftheOb-Gynisolates 13% oftheBfg had
reduced susceptibility to clindamycin (CL) com-
pared to 30% for IA isolates. Resistance to CL was
13% for Pept and Prev isolates from Ob-Gyn but
less (6% and 12%) for IA isolates. Ampicillin/
sulbactam (A/S) resistance ranged from 0 to 33%
for Bfg species and was 14% among Prev from
Ob-Gyn isolates. For IA isolates A/S resistance
ranged from 4 to 10% for Bfg and was 0% among
Prev, Porph and Pept. Cefoxitin (FOX) resistance
was 8% and 7% for Bfg isolates from Ob-Gyn and
IA sources respectively, but no resistance was
found among the other groups.
Conclusions: Antimicrobial resistance appears to
be increasing among both Ob-Gyn and IA isolates
to common antimicrobials; the Bfg plays a major
role in this resistance and accountsfor the majority
of the isolates in each group. Increasing CL and
A/S resistance may severely compromise their
current and/or future use. These data underscore
thechangingresistance amongclinically significant
anaerobes and indicate which agents may be most
useful empirically.
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Category Overall Hispanic Black Age < 19 Age ‡ 19
Ever had anal sex
Ever had oral sex
Recent anal sex
Recent oral sex
No protection – vaginal sex
No protection – anal sex
No protection – oral sex
23%
64%
15%
50%
40%
84%
94%
24%
65%
16%
53%
42%
88%
94%
20%
59%
13%
37%
33%
71%
92%
15%
51%
10%
36%
38%
82%
95%
30%
74%
19%
61%
41%
85%
93%
Table 1 Pattern of sexual activity in study group
Patterns of sexual activity among high-risk
minority women: implications for topical
microbicide development
J. M. Piper MD, R. N. Shain PhD, A. E. Holden
MA, S. Perdue DrPH and J. D. Champion PhD
Department of Obstetrics and Gynecology,
UTHSC-SA, San Antonio, TX
Objectives: Design of topical microbicides must
consider the differing surfaces to which they may
beapplied.Productsdesigned to preventthetrans-
mission ofsexually transmitted diseases (STDs)and
human immunodeficiency virus (HIV) in women
mustbesafeandeffectiveinthevaginaandpossibly
also the rectum and oral cavity. We sought to
describe the sexual activity patterns of minority
women with active STDs to determine the need
for rectal and/or oral efficacy and safety of topical
microbicides.
Study design: Minority women with an active
STD (gonorrhea, chlamydia or Trichomonas)
were questioned extensively about their recent
(previous three months) and lifetime sexual activ-
ity. Sexual activity patterns (including use of pro-
tection)are described below,stratified byethnicity
(Hispanic vs. Black) and age (< 19 vs. ‡ 19).
Results: All 827 participants reported recent
vaginal sex. Rates of reported anal and oral sex,
both lifetime and recent, are described below,
alongwith thepercentageofwomen whorecently
engaged in each type and never used protection(condoms or dental dams) with that type of sex
(Table 1).
Conclusions: High-risk minority women com-
monly engage in non-vaginal sexual activity, with
oral sex most common (~2/3) and anal sex
reported by a substantial minority (~1/4). Use of
protection for non-vaginal sex was rare. Although
a topical microbicide safe and efficacious only for
vaginal use would benefit women in our popula-
tion, there is a great need for the development of
microbicidesthatarealso safeandeffectiveforboth
oral and rectal use.
Vaginal microflora of sexually inexperi-
enced women: impact of sexual debut
S. L. Hillier PhD, M. A. Krohn PhD,
L. Meyn MS and D. V. Landers MD
University of Pittsburgh/Magee-Women’s Hospital,
Pittsburgh, PA
Objective: To describe the vaginal microflora of
sexually inexperienced women, and to assess the
impact of sexual debut on the vaginal ecosystem.
Study design: Ninety-seven women aged from
18to30whodeniedpreviousvaginal/penileinter-
course were recruited from 3 clinical sites. Vaginal
specimens were transported in Amies media for
detection of group B Streptococcus (GBS),
Lactobacillus, yeast and bacterial vaginosis (BV).
Vaginal micro-organisms were detected byculture
methods and BV was diagnosed using Gram-
stainedvaginalsmears evaluatedbytheNugentcri-
teria. Follow-up cultures and data were available
for 73 women at four-month intervals thereafter,
for a total of 67.6 woman-years of follow-up.
Results:Nineteen (19.6%)ofthevirginswerecol-
onized by GBS, 58 (59.8%) by hydrogen
peroxide-producing lactobacilli, 20 (20.6%) by
yeast, and 17 (17.5%) had Gram stain evidence of
BV. Initiation of vaginal intercourse was reported
by27(37.0%)ofthe73womenfollowedforayear.
The rates of acquisition of GBS, yeast and BV, and
rate of loss of H2O2-producing lactobacilli strati-
fiedbysexualbehavioraresummarizedinTable1.
Conclusions: Initiation of vaginal intercourse
leads to numerous changes in the vaginal micro-
flora. Engaging in vaginal intercourse was associ-
ated with increased acquisition of GBS, yeast and
BV, and unprotected intercourse was associated
with increased acquisition of BV and loss of
H2O2-producing lactobacilli.
Demographic and behavioral risk factors
for losing vaginal colonization with H2O2+
Lactobacillus spp.
M. A. Krohn PhD, L. A. Meyn MS and
S. L. Hillier PhD
Magee-Women’s Hospital/University of Pittsburgh,
Pittsburgh, PA
Objectives: To determine demographic,
behavorial, and sexual/hygiene factors that are
associated with loss of vaginal colonization with
H2O2+ Lactobacillus spp.
Studydesign:Thestudyisaprospective,longitu-
dinal, observational cohort study of 1248 non-
pregnant women observed at 4 monthly intervals
for 1 year from 1997 through 2001. Genital speci-
mens and a behavorial questionnaire were done at
each visit. Rates of lactobacilli loss were expressed
per100-womanyearsoffollow-upand assessed for
risk factors using Cox proportionalhazard models.
The values of exposure variables, assessed the visit
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Behavior GBS Yeast BV
Loss of H2O +
Lactobacillus
Recent sex
Yes
No
Unprotected sex
Yes
No
146*
42
47
47
208*
52
102
57
74*
12
134*
10
121
38
153*
37
Table 1 Rate of acquisition or loss of vaginal flora per
100 woman-years of follow-up (*p < 0.05)before losing colonization, were used in the
models.
Results: After adjusting for covariates, African-
American women(HR =1.5;1.1–2.0);thosewith
less than a high school education (HR = 2.5; 95%
CI, 1.5–4.1); and women not using alcohol
(HR = 1.5; 1.1–2.2) have elevated risks of
losing Lactobacillus colonization. Women using no
contraception(HR =1.5; 1.02–2.1), women with
intermediate flora(HR = 2.3; 1.7–3.1); thosewith
BV (HR = 2.8; 2.0–3.9); and women with yeast
(HR = 1.3; 1.03–1.8) had increased risks of losing
Lactobacillus. Womenusingoralcontraceptiveshad
a 30% reduced risk of losing colonization com-
pared with barrier users.
Conclusions: Surrogate demographic variables
such as race and education affect Lactobacillusstatus
by unknown mechanisms. However, proximal,
modifiable factors such as contraceptive methods
and other vaginal flora may influence the vaginal
environment to the benefit or harm of Lactobacillus
colonization.
Interaction between lactobacilli and
Gardnerella vaginalis in vitro as a key in the
pathogenesis of bacterial vaginosis
Alla Aroutcheva MD, PhD, Jose Simoes MD, PhD
and Sebastian Faro MD, PhD
Objective: To determine the factors producedby
Lactobacillus that inhibit the growth of Gardnerella
vaginalis and to study the ability of G. vaginalis to
overcome lactobacilli.
Study design: Forty-onevaginallactobacilliwere
studied for the productionof acids, hydrogen per-
oxide, and bacteriocin. Forty-three G. vaginalis
isolatesweretestedforgrowthinacidmedia,sensi-
tivity to H2O2, bacteriocin, and inhibition effect
on lactobacilli.
Results: Lactobacilli produce a large amount of
organic acids that maintain a low pH in the vaginal
environment. After 24 hours of growth the pH of
Lactobacillus species in liquid MRS medium
decreased from 6 to 5.1–4.0. Growth of Lacto-
bacillus and G. vaginalis at different media pH was
monitored with optical density (OD) within 48 h.
Inhibition rate was calculated by subtracting the
48 h OD from the initial OD for each tested pH
and control (pH 6.0). Taking the difference
between control OD as 100% we calculated the
percentage of inhibition. Media of pH 4.0 inhib-
ited 82% of G. vaginalis growth and 37% of
Lactobacillus; while at pH 4.5 the inhibition rates
were 52% and 14% respectively. Eighty-two per-
cent of the lactobacilli produced H2O2. Sensitivity
of G. vaginalis to H2O2 ranged from < 15 to
100 mg/ml. The72.7% of Lactobacillusisolates pro-
duced by bacteriocin inhibited growth of most of
the G. vaginalis strains (77.8%). Sensitivity of
G. vaginalis to purified bacteriocin (3.8 kDa)
ranged between 12.5 and 0.75 µg/ml. Our study
showed that G. vaginalis also produced factors
bacteriostatic for Lactobacillus. Lysate from three
G. vaginalis strains inhibited 79%, 73% and 55% of
Lactobacillus growth in MRS broth at pH 6.0. At
pH 4.0 the strains had decreased inhibition effects
of 48.4%, 40.1% and 15%.
Conclusion: In the healthy vaginal ecosystem
vaginal lactobacilli produce antibacterial factors
that maintain G. vaginalis under suppressed condi-
tions. However, G. vaginalis produces factors able
to inhibit the growth of Lactobacillus. This mecha-
nism probably takes place in vivo in cases of
bacterial vaginosis.
Do second-trimester amniotic fluid
interleukin-6 and interleukin-10 concentra-
tions predict preterm delivery?
Joseph Apuzzio MD, Ying Chan MD,
Nicholas Illsley PhD, Pei-Lin Kim MD and
Stanley Vonhaggen PhD
New Jersey Medical School, Newark, NJ
Objective: Interleukin-6 (IL-6) is an inflamma-
torycytokinethathasbeenshowntobeelevated in
the amniotic fluid of patients with preterm labor,
and interleukin-10(IL-10) isan anti-inflammatory
cytokine that has been shown to inhibit the
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amnioticfluidIL-10 in theearly secondtrimester is
low in patientswho subsequently develop preterm
labor. Because of its deficiency, excessive inflam-
matory responses associated with elevated levels of
IL-6 lead to preterm labor and delivery.
Study design: Amniotic fluid IL-6 and IL-10
levels were measured in 96 women who had
undergone genetic amniocentesis between 15 and
23 weeks’ gestation. Levels of IL-6 and IL-10
were measured by immunoassay and correlated
with demographic and pregnancy outcome
information.
Results: Fifteen patients delivered at or before 36
weeks and 81 patients delivered after 36 weeks.
There was an inverse correlation between
amniotic fluid IL-6 concentration and gestational
age at delivery. Similarly, an inverse correlation
existed between amniotic fluid IL-10 concentra-
tion and gestational age at delivery.
Conclusions: Both IL-6 and IL-10 levels in the
second-trimester amniotic fluid appear to be
higher in patients who subsequently undergo pre-
term delivery. Therefore,lowamnioticfluidIL-10
production during the second trimester does not
seem to be an etiology for preterm labor.
Tumor necrosis factor-alpha (TNF-a)
down-regulates oxytocin receptor binding
in cultured human uterine myocytes
P. N. Rauk MD
Magee-Women’s Research Institute and Department of
Obstetrics, Gynecology, and Reproductive Sciences,
University of Pittsburgh School of Medicine, Pittsburgh,
PA
Objective: Oxytocin receptor (OTR) increases
in themyometrium immediately priorto theonset
of bothterm and preterm labor.Intrauterineinfec-
tion accounts for as much as 70% of all cases of
preterm labor. Intrauterine infection results in the
production of decidual inflammatory cytokines,
specifically TNF-a and interleukin-1 and -6,
which stimulate prostaglandin production and
labor. We have previously demonstrated that IL-1
down regulates the OTR in human myometrium,
while IL-6 up-regulates the OTR1,2. The objec-
tive of this study was to evaluate the effect of
TNF-a on OTR in the human uterus.
Study design: Human uterine smooth muscle
from term unlabored uteri were established in
primary tissue culture. Cells were treated with
TNF-a at increasing concentrations(0–20 ng/ml)
and for various times (0–24 hours). Oxytocin
receptor binding was measured using 125I-labeled
oxytocin antagonist ornithine vasotocin (OVT).
Oxytocin receptor mRNA was measured using
semi-quantitative reverse transcriptionpolymerase
chain reaction (RT-PCR). Comparison between
TNF-a treated cells and controls was made using
ANOVA.
Results: The addition of TNF-a (0.1 and
1 ng/ml) resulted in a 25% and 50% reduction in
OVT binding at 24 hours respectively. Receptor
concentrationwas200±80 fmol/mgproteinwith
TNF-a (1 ng/ml) compared to 558 ± 200 in
treated control cells (p < 0.05). In time-course
experiments loss of binding was exponential after
8 hours of treatment. RT-PCR experiments
demonstrate a 50% reduction in oxytocinreceptor
mRNA beginningat 6hoursofTNF-atreatment.
Conclusions: These data demonstrate a sensitive
time- and dose-dependent down-regulation of
oxytocin receptor binding and oxytocin receptor
mRNA by TNF-a in the human uterus. The
down-regulation of prematurely induced uterine
oxytocin receptors by TNF-a may be a protective
mechanism limiting the preterm labor process in
early infection. With prolonged infection other
cytokines, especially IL-6, may subsequently
induce the expression of OTR.
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concentration in amniotic fluid and fetal
death in a rabbit model of chronic infection
M. Kunze1, J. K. Davies1, R. S. McDuffie2,
D. M. Wolf1, M. P. Sherman3, K. K. Leslie1 and
R. S. Gibbs1
1Department of Obstetrics and Gynecology, University
of Colorado School of Medicine; 2Kaiser Permanente,
Denver,CO; and 3DepartmentofPediatrics,University
of California, Davis School of Medicine
Objectives: Tumor necrosis factor-alpha
(TNF-a) has been implicated as a mediator of
septic shock and death, and has been detected in
human amniotic fluid duringpreterm labor due to
intra-amniotic infection. We investigated the
correlates of fetal death in a pregnant rabbit model
using inoculation of Escherichia coli with delayed
antibiotic therapy.
Study design: As reported previously (Gibbs
et al., IDSOG, 2000), New Zealand white rabbits
at 70% gestation were inoculated intracervically
with 103–104 cfu E. coli per uterine horn. We also
inoculated two controls with saline. At varying
intervals after inoculation (0.5–4.0 h), antibiotic
therapy was initiated with ampicillin-sulbactam.
Necropsy was performed after 72–120 hours.
Uterus, placenta, decidua and fetal tissues were
collected for culture. Histology was performed
using a semiquantitative histologic inflammation
(HI) score (based upon inflammation, congestion
andedema).Ameasure offetaldeathwasexpressed
as the ratio of number of dead pupsin uterodivided
by the total number of pups in utero (data not
reported in IDSOG 2000). Amniotic fluids from
these animals were analyzed for TNF-a levels by
bioassay (data not reported). Logistic regression
was carried out using SAS PROC GENMOD.
Results: Mean TNF-a levels in amniotic fluid
were 10–1000-fold greater than those in the saline
controls. The ratio of dead pups to total pups was
correlated with log TNF-a values in amniotic
fluid (see Figure 1). Theonly significant predictors
of fetal death were log TNF-a (p < 0.0001) and
uterine histologic inflammation score
(p < 0.0004), but not positive culture of amniotic
fluid, uterus, placenta or the fetus.
Conclusions: In a model of chronic infection
inducedbydelayedantibiotictherapy,fetaldeathis
independently correlated with log TNF-a level
and uterine HI score, but not with culture status.
Fetal death in this setting is not associated with
infection per se, but rather with the host’s response
to infection.
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Figure 1 Fraction of dead pups against TNF-a level
Decreased cervical proinflammatory
cytokines in early pregnancy are associated
with subsequent intra-amniotic infection
H. N. Simhan MD, M. A. Krohn PhD,
S. N. Caritis MD, B. Martinez de Tejada MD,
D. V. Landers MD and S. L. Hillier PhD
University of Pittsburgh/Magee-Women’s Hospital,
Pittsburgh, PA
Objective:Todeterminetheassociation between
the concentration of cervical proinflammatory
cytokines early in pregnancy and the subsequent
development of clinical intra-amniotic infection
(IAI) in labor.
Study design: We enrolled 517 women from
February 1996 to February 1997, of whom 403
had complete data. Two cervical swabs were
collected at 8–20 weeks’ gestation for the assay ofinterleukin-1b (IL-1b), interleukin-6 (IL-6), and
interleukin-8 (IL-8). Cytokine concentration was
measured by a commercially available enzyme
linked immunosorbentassay (ELISA). Swabs were
tested for Trichomonas vaginalis, Chlamydia tracho-
matis, Neisseria gonorrhoeae, bacterial vaginosis, and
Group B Streptococcus. IAI was diagnosed by a
temperature higher than 38o C and two of the
followingsigns:maternal/fetal tachycardia,uterine
tenderness, foul smelling vaginal discharge, and
white blood cell count (WBC) > 18 000. The
univariateand adjusted oddsratios forthedevelop-
mentofIAIbycytokineconcentrationslowerthan
the first quartile were determined using logistic
regression analysis. Several demographic, clinical,
and infectious factors were assessed for effect-
modification and confounding.
Results: Median concentrations of IL-1b, IL-6
and IL-8 are significantly decreased amongwomen
who subsequently develop IAI (Table 1 and
Figure 1).
Conclusions: Decreased concentrations of cervi-
cal proinflammatory cytokines early in pregnancy
are strongly associated with the development of
subsequent IAI in labor, even when adjusted for
obstetric and infectious risk factors.
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Cytokine
Unadjusted
OR
Adjusted
OR* 95% CI p
IL-1b <
first quartile
3.00 3.41 1.47–7.89 0.004
IL-6 < first
quartile
2.66 2.52 1.14–5.55 0.022
IL-8 < first
quartile
2.34 2.60 1.20–5.66 0.016
Table 1 Statistical analysis of the data
Figure 1 Median concentrations of interleukins IL-1b, IL-6 and IL-8; IAI, intra-amniotic infection
Relationship between maternal and fetal
antibodies to vaginal anaerobes and
preterm birth
K. A. Boggess, S. Lieff, A. P. Murtha,
P. Madrianos, J. Beck and S Offenbacher
University of North Carolina and Duke University,
Chapel Hill, NC
Objective: Our objective was to determine
whether maternal or fetal humoral responses to
vaginalanaerobesare associated withpreterm birth
(PTB).
Study design: A prospective cohort of pregnant
women was enrolled at < 26 weeks’ gestation.
Maternal demographic and medical information
waschart abstracted.Maternal serum was collected
at enrollment and at delivery and analyzed for IgG
to Gardnerella vaginalis, Prevotella bivius, Mobiluncus
curtsii, and Bacteroides urealyticus. Umbilical cord
serum was collected following delivery and
analyzed for IgM to the same organisms. PTB was
defined as delivery at less than 37 weeks as a result
of preterm labor or premature rupture of
membranes. Correlation was performed using
Spearman rank correlation.
Results: 293 (78.1%) of 375 maternal samples
collected at enrollment were IgG+ for any
organism,comparedto194(49.1%)of395samples
collected at delivery. Demographic characteristics
were similar between antibody-positive and
antibody-negative women with regard to age,insurance marital status, parity and tobacco use.
The presence of maternal antibody at enrollment
was correlated with maternal antibody at delivery
(r = 0.59, p = 0.04). There was a negative correla-
tion between antibody at delivery and BV during
pregnancy (r = –0.36, p = 0.04). The presence of
maternal antibody at enrollment or delivery
was negatively associated with fetal antibody
(r = –0.34, p = 0.06 and r = –0.41, p = 0.05,
respectively). The rate of PTB of the entire cohort
was26%.Womenwhowereantibody+atdelivery
orwhosefetuseswereantibody+werelesslikely to
have PTB (Table 1).
The PTB rate was highest in women who were
antibody-positive at enrollment and whose fetuses
were antibody-negative (49%).
Conclusion: Exposure to vaginal anaerobes with
an inadequate maternal or fetal humoral response
may be related to the causal mechanism between
BV and prematurity.
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Does the clinical setting influence vaccine
awareness in obstetric and gynecology
patients?
Bernard Gonik MD and Mark Tomlinson MD
DepartmentofObstetricsandGynecology,Wayne State
University School of Medicine, Detroit, MI and
Women’s Healthcare Association, Portland, OR
Objective: To better understand patient vaccine
awareness in different clinical settings.
Study design: A survey was completed by
patients at an obstetric and gynecology resident
teaching clinic (CLINIC) (n = 228) and byprivate
community physician patients (PVT) (n = 254).
The masked questionnaires contained yes/no or
multiple choice questions exploring demographic,
immunization recollection and vaccine adminis-
tration preferences for these two study popula-
tions. Chi-square for categorical variables and
Student’s t-test for continuousvariables were used
for statistical analyses.
Results: The CLINIC group were younger than
thePVT group(27.2 ± 10.6 yrsvs.38.0 ± 12.6 yrs;
p < 0.001) and presented more often for preg-
nancy-related visits (57.0% vs. 21.6%; p < 0.001).
PVT more commonly had documentation of
childhood(34.3%)andadult(26.8%)vaccinestatus
than CLINIC (25.6% and 15.5%, respectively)
(p < 0.03). Of the vaccine-preventable diseases
(VPD) surveyed, PVT (vs. CLINIC) more often
reportedadequatevaccinationorpriorexposureto
rubella (68.5% vs. 30.5%; p < 0.001) and varicella
(65.7% vs. 48.5%; p < 0.001). No differences were
noted between the study groups for hepatitis B,
tetanus, and influenza. The adequacy of vaccina-
tion for these latter VPD was below 50% for both
PVT and CLINIC groups. The PVT group more
often identified a non-obstetric/gynecological
primary care provider for vaccine-related needs, as
opposed to the CLINIC group, who more often
relied on their obstetric and gynecological or
healthdepartmentsites. Overa thirdofbothpopu-
lations could not identify a provider for vaccine
administration. Both The PVT group (78.8%) and
the CLINIC group (84.0%) strongly desired avail-
ability of vaccine services through their obstetric
and gynecological office.
Conclusions: Private community physician
patients demonstrate a better awareness of vaccine
status than do those attending a teaching clinic.
However, overall both populations report poor
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Rate of PTB Rate of PTB OR (95% CI)
Maternal antibody+ at enrollment
Maternal antibody+ at delivery
Fetal antibody+
78%
38%
44%
Maternal antibody– at enrollment
Maternal antibody– at delivery
Fetal antibody–
22%
62%
56%
1.0 (0.59–1.8)
0.64 (0.45–0.92)
0.66 (0.45–0.97)
Table 1 Rates of preterm birth (PTB) correlated with antibody statusdocumentation and inadequate immunity against
most VPD. A variety of practice sites are currently
utilized for vaccination, although many patients
cannot identify a place to go. The majority of
patients would like to see this service available as a
part of their obstetric and gynecological care.
Point mutation in Escherichia coli Dr
fimbriae abolishes type IV collagen-binding
and renal persistence in experimental
chronic pyelonephritis
Rangaraj Selvarangan1, Pawel Goluszko1,
Jyotsana Singhal1, Christophe Carnoy2,
Steve Moseley3, Billy Hudson4, Stella Nowicki1 and
Bogdan J. Nowicki1
1Departments of Obstetrics and Gynecologyand Micro-
biologyandImmunology,UTMed.Branch,Galveston,
TX-77555-1062; 2Institute de Biologie de Lille,Lille,
FRANCE; 3Univesity of
Washington, Seattle,WA; 4University ofKansas Med-
ical Center, Kansas city, KS
Introduction: The role of Escherichia coli viru-
lence factors in recurrent and chronic infections of
the urinary tract is poorly understood. The Dr
fimbriae of E. coli display unique tropism to the
renal interstitium enabling the bacterium to cause
experimental chronic pyelonephritis in mice.
The renal receptors for Dr+ E. coli are decay-
accelerating factor (DAF) and type IV collagen.
While the total loss of Dr fimbrial binding activity
resulted in prevention of experimental chronic
pyelonephritis, the contribution of the individual
receptorsto the chronicinfectiousprocessrequires
further investigation. The apical cellular receptor,
DAF mediates colonization and internalization of
the Dr+ E. coli into epithelial cells.
Objectives: We hypothesized that the access of
bacteria to the basement membrane collagen pro-
vides protected colonization sites for Dr+ E. coli
and promotes chronicity.
Study design: To test this hypothesisand the role
of type IV collagen in the renal persistence of Dr+
E. coliweconstructedan isogenic mutantI113T in
the DraE adhesin subunit retaining DAF binding
but unable to bind type IV collagen. The mutant
lost interstitial binding to both human and mouse
kidneys. The parent strain E. coli IH11128 and its
collagennon-bindingisogenic mutantI113Twere
evaluated for persistence of infection in an estab-
lished model of tubulo-interstitial nephritis in
C3H/HeJ mice. Groups of mice were infected
intravesically and sacrificed at different time points
for quantitative culture of the kidneys.
Results: The mice infected with collagen mutant
Dr-I113T eliminated infection by 8 weeks while
the parent strain caused persistent infection that
lasted at least 14 weeks (p £ 0.02). A trans-
complementation experiment that restored type
IV collagen and kidney-binding also restored the
capacitytocausepersistentinfection.Weconclude
that DraE-mediated type IV collagen binding is
necessary for the development of chronic pyelon-
ephritis in a murine model of E. coli urinary tract
infection.
Perioperative antimicrobial prophylaxis can
be improved with regard to urinary tract
infection by means of a long-acting
cephalosporin such as ceftriaxon
UB Hoyme and Katrin Schönheit
Department of Gynaecology and Obstetrics, Klinikum
Erfurt, Germany
Objectives: Having determined the requirement
for antimicrobial prophylaxis in both obstetrical
and gynecological procedures most studies
demonstrated similar efficacy irrespective of agent
or number of doses. For that reason we sought to
ascertain any difference in urinary tract infection
associated with the half life of pharmakon.
Study design: In a prospective randomized com-
parative study 2 g mezlocillin (Baypen, Bayer,
Leverkusen) (n = 250), 2 g cefotiam (Spizef,
Takeda/Grünenthal, Aachen) (n = 299) or 1 g
ceftriaxon (Rocephin, Roche, Grenzach-
Wyhlen) (n = 263) was administered iv as
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obstetrical or gynecological surgical procedures.
Results: There was a 6.0% overall prevalence of
wound infection with no difference between the
studygroups.Atotalof136womenacquireda uri-
nary tract infection: 21.6% following mezlocillin
vs. 16.4% following cefotiam and 12.5% in the
ceftriaxon group (p < 0.05).
Postoperative antibiotics were administered in
21.9% of all patients (88.0% because of urinary
tract infection): 25.6% in the mezlocillin group vs.
24.1% following cefotiam, and 16.0% after treat-
ment with ceftriaxon (p < 0.5).
Conclusion: The rate of postoperative urinary
tract infections could be reduced following pro-
phylaxis with the long-acting third generation
cephalosporin ceftriaxon in comparison to
standard antibiotics.Thisled to a furtherreduction
in the use of antibiotics for postoperative
complications.
Progression of periodontal disease during
pregnancy is associated with an increased
risk for preterm delivery
A. P. Murtha1, S. Lieff2,D. E. Abel1,
R. P. Heine1, K. A. Boggess2, H. L. Jared2 and
S. Offenbacher2
1Department of Obstetrics and Gynecology, Duke Uni-
versityMedicalCenter,Durham,NC; 2UNCSchool of
Dentistry, Chapel Hill, NC
Objective:Preliminary datasuggestanassociation
between periodontal disease and preterm birth.
Our objective was to determine whether the pro-
gression of periodontaldisease duringpregnancyis
associated with an increase risk for preterm birth.
Study design: The Oral Conditions and Preg-
nancy study is a prospective study to examine the
relationship of preterm birth to periodontal
disease. Oral examinations are performed prior to
26 weeks’ gestation and repeated within 48 hours
of delivery. Pocket depth was measured at 6 sites
on each tooth with a periodontal probe. Peri-
odontal disease was defined as 4 sites with ‡ 5 mm
pocket depth. Progression of periodontal disease
was defined as 4 sites with ‡ 2 mm increase in
pocket depth. Subjects with periodontal disease at
baseline were divided into those with and without
progression. Preterm birth was defined as delivery
prior to 37 weeks. Data were analyzed using Chi
square and logistic regression.
Results: Of the 722 subjects who completed both
oral exams, 88 had periodontaldisease at the base-
line exam. Of these 88 subjects 32 (36.4%) had
progression of periodontal disease during preg-
nancy. The preterm birth rate was significantly
higher in the presence of progression when com-
pared to those without progression (47% vs. 27%,
p = 0.04). After controlling for potential con-
founders including race, marital status and prior
preterm birth an odds ratio of 4.97 (1.5–16.1) was
obtained.Theadjustedoddsratiofordeliveryprior
to 35 weeks in women with periodontal disease
progression was 5.94 (1.5–22.9).
Conclusions: Progression of periodontal disease
during pregnancy is associated with a five-fold rise
in the risk for preterm birth. Progression of peri-
odontaldisease is associated with an increased local
inflammatory response and infectious burden that
may be manifest not only as a local progression of
the disease but also as systemic effects ultimately
leadingto preterm birth.Furtherresearch to estab-
lish a causal pathway is in progress.
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cord as an indicator of intrauterine inflam-
mation and neonatal morbidity among
preterm infants
Carolyn Gardella MD, Jane Hitti MD, MPH,
Dorothy Patton PhD and David Eschenbach MD
Departmentof Obstetrics andGynecology, University of
Washington, Seattle, WA
Objectives: To describe the histopathology of
theumbilical cordas it relates tointrauterineinfec-
tion and inflammation and to determine if funisitis
is associated with neonatal morbidity among
preterm infants.
Study design: A cohort of 115 afebrile women
with preterm labor and intact membranes who
ultimately delivered at less than 34 weeks had
amniotic fluid (AF) collected by transabdominal
amniocentesis for culture and for interleukin
(IL)-6, IL-8 and tumor necrosis factor-alpha
(TNF-a) levels. After delivery the chorioamnion
and umbilical cord histology were examined and
neonatal outcomes were recorded. Funisitis was
systematically graded based on the presence of ‡ 5
neutrophils in the umbilical vessels or Wharton’s
jelly (0 = none, 1 = present in 1 vessel, 2 = present
in 2–3 vessels, 3 = present in Wharton’s jelly). AF
and chorioamnion characteristics and neonatal
outcomeswerecomparedbythegradeoffunisitis.
Results: The results are shown in Table 1.
Conclusions: Funisitis grade > 0 was strongly
associated with indicators of AF inflammation and
histologic chorioamnionitis. Neonatal morbidity
was associated with grade of funisitis. The risk of
neonatal morbidity was greatest among infants
with the higher grades of funisitis relative to those
without funisitis, but these associations did not
reach statistical significance. Histologic evaluation
of the umbilical cord is technically easy and may
have clinical applications to provide information
about the intrauterine milieu retrospectively.
Further study of the association between funisitis
and neonatal morbidity is warranted.
Acknowledgement
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Grade of funisitis
0
(n = 84)
1
(n = 7)
2
(n = 13)
3
(n = 11) p*
Amniotic fluid (%)
Culture+ 6 57 23 46 < 0.001
IL-6 > 2000 pg/ml 19 71 54 80 < 0.001
TNF-a > 30 pg/ml 10 71 46 50 < 0.001
Culture+ or cytokine+ 33 71 62 90 0.001
Chorioamnion (%)
Culture+ 8 29 8 18 0.3
Histologic chorioamnionitis 21 100 85 82 < 0.001
Necrotic membrane roll 14 17 23 46 0.2
Neonatal outcome
Delivery EGA (median, wks) 31 31 28 29 0.1
Birth weight (median, g) 1700 1542 1351 1439 0.1
Any morbidity†, % 50 43 75 90 0.04
RR (95% CI) (Ref) 0.4 (0.1–1.3) 1.4 (0.4–4.6) 4.2 (0.8–21.5)
aRR (95% CI) (Ref) 0.3 (0.1–1.4) 1.3 (0.3–5.3) 3.6 (0.6–21.2)
*c
2 or Kruskall Wallis, as appropriate; †includes: RDS, sepsis,NEC, grade 3 or 4 IVH, or death; RR, relative risk; aRR, relative risk adjusted
for birth weight
Table 1 Histology of umbilical cord and chorioamnion correlated with presence of neutrophilsCerebral palsy, Escherichia coli and group B
Streptococcus
H. M. McDonald1 PhD, S. Aitchison2 BSc,
J. E. Hiller2 PhD, T. Y. Khong1 FRCPA,
J. S. Robinson2 FRACOG and
R. Vigneswaran1FRCP
1Women’s & Children’s Hospital (WCH), Adelaide,
Australia; 2UniversityofAdelaide,Adelaide,Australia
Objective:To determinetheassociation between
chorioamnionitis and cerebral palsy (CP) in very
low birthweight infants.
Study design: In a case-cohort study all very low
birthweight (VLBW) infants born at the WCH
whodevelopedCPthatwasconfirmedat 5yearsof
age, were included (n = 82). The comparison
group(sub-cohort)was a randomsample of infants
from the WCH VLBW database, which follows
infants from birth to seven years of age. As this
random sampling did not exclude CP cases, 24
infantswhohad CPwerealso randomlychosenfor
the sub-cohort and therefore formed a third group
in the analysis. Selection criteria for the database
changed slightly over the time period of the study,
and selection of the sub-cohort was stratified to
reflect these changes. More than 92 variables were
analyzed and related to the occurrence of CP.
Histopathological examination (n = 175) and
microbiological culture (n = 90) of the placenta
(interface between amniochorionic membranes)
were performed.
Results: Threatened preterm labor without
preterm delivery (TPTL), neonatal sepsis, placen-
tal E. coli and group B Streptococcus (GBS) and
were significantly associated with CP (Table 1).
Conclusion: Very low birthweight infants with
E. coli or group B Streptococcus infection of the
amniochorionic membranes have more than four
times the risk of CP.
‘Real world’ compliance with strategies to
prevent early onset group B streptococcal
disease
L. Riley MD, M. Apollon MD, S. Haider MD,
MPH, S. Chan-Flynn CNM, M. Rein MD,
A. Cohen, J. Ecker MD and
E. Lieberman MD, DrPH
Harvard Medical School
Objective: To assess the ‘real-world’ compliance
with risk-based and culture-based strategies to
prevent early onset group B Streptococcal (GBS)
disease.
Study design: We reviewed the medical records
of consecutive term pregnancies delivered at 3
institutions (hospitals A and B were academic
institutions and hospital C a community hospital)
between January and March 1998. We abstracted
demographic data, risk factors for GBS, GBS
culture information, intrapartum antibiotic
prophylaxis (IAP) and adverse drug reactions.
Results: At hospital A (n = 314), where the
culture-based strategy is employed, 297 women
(94.6%) had GBS cultures performed between 35
and 37 weeks’ gestation and documented in the
laborrecord.Of58womenwithpositiveGBScul-
tures, all received IAP.Of 17 women of unknown
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CP not sub-cohort,
n = 58
Subcohort not CP,
n = 183
CP & sub-cohort,
n = 24 Hazard ratio 95% CI
Clinical chorioamnionitis 6/58 24/183 3/24 ns
Histological chorioamnionitis 10/33 37/124 10/18 ns
TPTL 11/58 14/183 4/24 2.2 1.1–4.5
Placental E. coli 6/19 3/61 0/10 4.6 1.2–18.5
Placental GBS 3/19 3/61 2/10 4.1 1.3–12.9
Neonatal sepsis 13/58 25/183 5/24 2 1.0–4.0
Table 1 Histological and microbiological findingsGBS status, 3 had risk factors and received IAP. At
hospital B (n = 335), where the risk-based strategy
is employed, 53 women (15.8%) had risk factors
for GBS, of whom 48 (90.6%) were treated appro-
priately with IAP. At hospital C (n = 178), 116
women had risk-based strategies applied and 62
had the culture-based strategy. Of women in the
risk-based strategy, 20 (17.2%) had risk factors and
19/20 (95%) received IAP. Of women in the
culture-based strategy, 38 (61.3%) had culture
status documented in labor. Nine women with
positive cultures received IAP. Of 27 with
negative cultures, 5 (18.5%) received IAP. Among
24%, 18.8% and 19.1% of women receiving
antibiotics at hospitals A, B and C respectively,
only one minor adverse drug reaction (hives) was
noted.
Conclusions: Compliance with the risk-based
strategy was 91.8 % while compliance with the
culture-based strategy was 100 %. There was a
tendency to combine strategies in the culture-
basedapproachleadingtoanoveruseofantibiotics.
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